Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−6.64 USD
−24.91 M USD
225.00 K USD
9.14 M
About iBio, Inc.
Sector
CEO
Martin B. Brenner
Headquarters
San Diego
Website
Founded
1993
FIGI
BBG000D5F2L9
iBio, Inc. is an AI-driven innovator that develops next-generation biopharmaceuticals using computational biology and 3D-modeling of subdominant and conformational epitopes, prospectively enabling the discovery of new antibody treatments for hard to target cancers, and other diseases. It focuses on decreasing drug failures, shortening drug development timelines and opening up new frontiers against the most promising targets. The company was founded on April 17, 2008 and is headquartered in San Diego, CA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of IBIO is 2.45 USD — it has increased by 11.87% in the past 24 hours. Watch iBio, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on AMEX exchange iBio, Inc. stocks are traded under the ticker IBIO.
IBIO stock has risen by 8.41% compared to the previous week, the month change is a −20.97% fall, over the last year iBio, Inc. has showed a −54.58% decrease.
We've gathered analysts' opinions on iBio, Inc. future price: according to them, IBIO price has a max estimate of 3.60 USD and a min estimate of 3.60 USD. Watch IBIO chart and read a more detailed iBio, Inc. stock forecast: see what analysts think of iBio, Inc. and suggest that you do with its stocks.
IBIO reached its all-time high on Jan 18, 2011 with the price of 30,300.00 USD, and its all-time low was 1.02 USD and was reached on Jan 18, 2024. View more price dynamics on IBIO chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
IBIO stock is 12.33% volatile and has beta coefficient of 2.32. Track iBio, Inc. stock price on the chart and check out the list of the most volatile stocks — is iBio, Inc. there?
Today iBio, Inc. has the market capitalization of 20.04 M, it has increased by 1.86% over the last week.
Yes, you can track iBio, Inc. financials in yearly and quarterly reports right on TradingView.
iBio, Inc. is going to release the next earnings report on Feb 18, 2025. Keep track of upcoming events with our Earnings Calendar.
IBIO earnings for the last quarter are −0.46 USD per share, whereas the estimation was −0.46 USD resulting in a 0.00% surprise. The estimated earnings for the next quarter are −0.45 USD per share. See more details about iBio, Inc. earnings.
iBio, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
IBIO net income for the last quarter is −3.99 M USD, while the quarter before that showed −7.78 M USD of net income which accounts for 48.71% change. Track more iBio, Inc. financial stats to get the full picture.
No, IBIO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 22, 2024, the company has 19.00 employees. See our rating of the largest employees — is iBio, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. iBio, Inc. EBITDA is −14.36 M USD, and current EBITDA margin is −6.84 K%. See more stats in iBio, Inc. financial statements.
Like other stocks, IBIO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade iBio, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So iBio, Inc. technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating iBio, Inc. stock shows the sell signal. See more of iBio, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.